Home › Heart Failure › Indiana
Heart Failure clinical trials in Indiana
29 studies for Heart Failure are looking for participants at sites in Indiana.
Cities in Indiana
- Indianapolis23 studies
- Hammond8 studies
- Richmond6 studies
- Evansville6 studies
- South Bend5 studies
- Gary4 studies
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Elkhart
- Research Site, Evansville
- Research Site, Muncie
- and 1 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 2, 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Midwest Cardiovascular Research and Education Foundation, Elkhart
- St. Francis Medical Group-Indiana Heart Physicians, Inc, Indianapolis
- Cardiovascular Research of Northwest Indiana, LLC, Munster
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Midwest Cardiovascular Research and Education Foundation, Elkhart
- St. Francis Medical Group-Indiana Heart Physicians, Inc, Indianapolis
- Indiana Medical Research Institute, Merrillville
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06424288A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Cardiovascular Research of Northwest Indiana, LLC., Munster
- Deaconess Heart Group, Newburgh
- Reid Physician Associates, Richmond
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Midwest Cardiovascular Research And Education Foundation, Elkhart
- Ascension Medical Group, Indianapolis
- Cardiovascular Research of Northwest Indiana LLC, Munster
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Indianapolis
- Research Site, Munster
- Research Site, Richmond
- and 1 more
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10064, Merrillville, IN, Merrillville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Indianapolis, IN Investigative Site 10074, Indianapolis
- Indianapolis, IN Investigative Site 10008, Indianapolis
- Merrillville, IN Investigative Site 10064, Merrillville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Ascension St. Vincent Hospital - Indianapolis, Indianapolis
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Community Heart and Vascular Hospital, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07069738A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 166, Indianapolis
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Evansville
- Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Indiana. University, Indianapolis
- Franciscan Physician Network-Indiana Heart Physicians, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Indianapolis
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Asha Clinical Rsch-Munster, LLC, Hammond
- Indiana University Health Methodist Hospital, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Indiana University, Indianapolis
Recruiting
Ages 40 and older · All sexes · Updated Aug 14, 2026 · NCT05685303Assessment of CCM in HF With Higher Ejection Fraction
- Ascension Medical Group St. Vincent, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05064709A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10064, Merrillville, IN, Merrillville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06033950A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Riley Hospital For Children - Cardiology, Indianapolis
RecruitingPhase 3
Up to age 18 · All sexes · Updated Jun 29, 2026 · NCT07192952PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Ascension St. Vincent's, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487Pediatric Cardiomyopathy Mutation Analysis
- IU School of Medicine, Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Jun 22, 2026 · NCT02432092Palliative Care for People With HF
- IUHealth, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT07356843A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Riley Hospital For Children - Cardiology, Indianapolis
RecruitingPhase 3
6 Months – 17 Years · All sexes · Updated Jun 15, 2026 · NCT07188805Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- St. Vincent Hospital, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- NexGen Research, Fort Wayne
- Reid Physician Associates, Richmond
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated May 27, 2026 · NCT06991257The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Community Health Network, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152Left vs Left Randomized Clinical Trial
- Trustees of Indiana University, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05650658HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
- Indiana University, Bloomington
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated May 22, 2024 · NCT06425848From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.